Uniphos Enterprises Limited Logo

Uniphos Enterprises Limited

UNIENTER.NS

(2.2)
Stock Price

144,08 INR

1.86% ROA

1.49% ROE

29.34x PER

Market Cap.

11.310.233.454,00 INR

0% DER

3.5% Yield

40.96% NPM

Uniphos Enterprises Limited Stock Analysis

Uniphos Enterprises Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Uniphos Enterprises Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.3x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

The stock's ROE falls within an average range (1.29%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (1.2%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

6 Dividend Growth

With a history of consistent dividend increases over the last three years, the company has proven to be a reliable choice for investors seeking reliable income.

7 Dividend

The company has consistently provided dividends over the past three years, indicating a reliable source of income for investors.

8 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

10 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (6), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Uniphos Enterprises Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Uniphos Enterprises Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Uniphos Enterprises Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Uniphos Enterprises Limited Revenue
Year Revenue Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 93.888.000 100%
2012 11.076.000 -747.67%
2013 90.750.000 87.8%
2014 19.124.000 -374.53%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 2.268.000 100%
2020 8.327.000 72.76%
2021 12.218.000 31.85%
2022 14.719.000 16.99%
2023 0 0%
2023 506.479.000 100%
2024 121.028.000 -318.48%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Uniphos Enterprises Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Uniphos Enterprises Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 2.207.000
2007 3.628.960 39.18%
2008 11.119.720 67.36%
2009 15.448.200 28.02%
2010 8.361.780 -84.75%
2011 3.046.000 -174.52%
2012 2.223.000 -37.02%
2013 3.352.000 33.68%
2014 3.528.000 4.99%
2015 2.478.000 -42.37%
2016 3.677.000 32.61%
2017 4.008.000 8.26%
2018 3.902.000 -2.72%
2019 3.537.000 -10.32%
2020 3.764.000 6.03%
2021 8.715.000 56.81%
2022 3.336.000 -161.24%
2023 4.204.000 20.65%
2023 5.683.000 26.02%
2024 4.268.000 -33.15%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Uniphos Enterprises Limited EBITDA
Year EBITDA Growth
2006 38.940.000
2007 33.307.040 -16.91%
2008 29.951.410 -11.2%
2009 24.195.660 -23.79%
2010 43.100.560 43.86%
2011 99.414.000 56.65%
2012 4.495.000 -2111.66%
2013 65.837.000 93.17%
2014 97.051.000 32.16%
2015 122.210.000 20.59%
2016 112.877.000 -8.27%
2017 -20.163.000 659.82%
2018 -28.101.000 28.25%
2019 -15.828.000 -77.54%
2020 -43.993.000 64.02%
2021 -48.110.000 8.56%
2022 414.361.000 111.61%
2023 1.573.632.000 73.67%
2023 -30.902.000 5192.33%
2024 -30.068.000 -2.77%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Uniphos Enterprises Limited Gross Profit
Year Gross Profit Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 3.046.000 100%
2012 319.000 -854.86%
2013 2.773.000 88.5%
2014 719.000 -285.67%
2015 -8.582.000 108.38%
2016 -216.000 -3873.15%
2017 -51.000 -323.53%
2018 -19.000 -168.42%
2019 21.000 190.48%
2020 75.000 72%
2021 123.000 39.02%
2022 164.000 25%
2023 0 0%
2023 -19.281.999 100%
2024 -18.320.000 -5.25%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Uniphos Enterprises Limited Net Profit
Year Net Profit Growth
2006 -7.151.000
2007 -48.600.160 85.29%
2008 60.458.640 180.39%
2009 198.449.110 69.53%
2010 -18.327.780 1182.78%
2011 11.868.000 254.43%
2012 -101.847.000 111.65%
2013 -16.311.000 -524.41%
2014 85.223.000 119.14%
2015 117.952.000 27.75%
2016 112.625.000 -4.73%
2017 176.880.000 36.33%
2018 207.646.000 14.82%
2019 200.744.000 -3.44%
2020 244.511.000 17.9%
2021 546.037.000 55.22%
2022 392.254.000 -39.2%
2023 1.574.508.000 75.09%
2023 386.143.000 -307.75%
2024 -5.888.000 6658.14%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Uniphos Enterprises Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 0
2007 -2 100%
2008 2 150%
2009 8 71.43%
2010 -1 0%
2011 0 0%
2012 -4 100%
2013 0 0%
2014 1 100%
2015 2 0%
2016 2 0%
2017 3 50%
2018 3 0%
2019 3 0%
2020 4 33.33%
2021 8 57.14%
2022 6 -40%
2023 23 77.27%
2023 6 -340%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Uniphos Enterprises Limited Free Cashflow
Year Free Cashflow Growth
2006 -335.564.000
2007 479.388.650 170%
2008 -82.335.370 682.24%
2009 -649.557.860 87.32%
2010 -5.163.980 -12478.63%
2011 -69.303.000 92.55%
2012 36.721.000 288.73%
2013 50.794.000 27.71%
2014 -78.367.000 164.82%
2015 -23.976.000 -226.86%
2016 -17.219.000 -39.24%
2017 -33.758.000 48.99%
2018 -32.138.000 -5.04%
2019 -21.067.000 -52.55%
2020 -45.870.000 54.07%
2021 5.203.000 981.61%
2022 -14.664.000 135.48%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Uniphos Enterprises Limited Operating Cashflow
Year Operating Cashflow Growth
2006 -23.385.000
2007 480.900.650 104.86%
2008 -75.310.100 738.56%
2009 -643.787.070 88.3%
2010 -2.957.180 -21670.3%
2011 -3.796.000 22.1%
2012 36.721.000 110.34%
2013 50.794.000 27.71%
2014 -78.367.000 164.82%
2015 -23.976.000 -226.86%
2016 -17.219.000 -39.24%
2017 -33.687.000 48.89%
2018 -32.138.000 -4.82%
2019 -21.067.000 -52.55%
2020 -45.870.000 54.07%
2021 5.203.000 981.61%
2022 -14.664.000 135.48%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Uniphos Enterprises Limited Capital Expenditure
Year Capital Expenditure Growth
2006 312.179.000
2007 1.512.000 -20546.76%
2008 7.025.270 78.48%
2009 5.770.790 -21.74%
2010 2.206.800 -161.5%
2011 65.507.000 96.63%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 71.000 100%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Uniphos Enterprises Limited Equity
Year Equity Growth
2006 357.422.000
2007 308.822.080 -15.74%
2008 369.280.720 16.37%
2009 567.729.830 34.95%
2010 1.999.402.050 71.61%
2011 2.011.270.000 0.59%
2012 1.909.423.000 -5.33%
2013 2.631.211.000 27.43%
2014 2.716.434.000 3.14%
2015 2.834.386.000 4.16%
2016 2.947.011.000 3.82%
2017 20.898.741.000 85.9%
2018 26.976.404.000 22.53%
2019 15.178.109.000 -77.73%
2020 27.147.087.000 44.09%
2021 31.805.307.000 14.65%
2022 29.975.988.000 -6.1%
2023 20.754.537.000 -44.43%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Uniphos Enterprises Limited Assets
Year Assets Growth
2006 1.178.653.000
2007 1.211.903.610 2.74%
2008 1.401.371.970 13.52%
2009 1.320.244.750 -6.14%
2010 2.734.086.940 51.71%
2011 2.973.581.000 8.05%
2012 2.824.479.000 -5.28%
2013 2.807.325.000 -0.61%
2014 2.820.506.000 0.47%
2015 2.836.472.000 0.56%
2016 2.948.554.000 3.8%
2017 20.900.373.000 85.89%
2018 26.978.160.000 22.53%
2019 15.185.193.000 -77.66%
2020 27.716.127.000 45.21%
2021 33.015.658.000 16.05%
2022 30.954.673.000 -6.66%
2023 20.775.038.000 -49%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Uniphos Enterprises Limited Liabilities
Year Liabilities Growth
2006 821.231.000
2007 903.081.530 9.06%
2008 1.032.091.250 12.5%
2009 752.514.920 -37.15%
2010 734.684.890 -2.43%
2011 962.311.000 23.65%
2012 915.056.000 -5.16%
2013 176.114.000 -419.58%
2014 104.072.000 -69.22%
2015 2.086.000 -4889.07%
2016 1.543.000 -35.19%
2017 1.632.000 5.45%
2018 1.756.000 7.06%
2019 7.084.000 75.21%
2020 569.040.000 98.76%
2021 1.210.351.000 52.99%
2022 978.685.000 -23.67%
2023 20.501.000 -4673.84%

Uniphos Enterprises Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
13.53
Net Income per Share
5.54
Price to Earning Ratio
29.34x
Price To Sales Ratio
12.02x
POCF Ratio
-1075.12
PFCF Ratio
-1075.12
Price to Book Ratio
0.54
EV to Sales
11.51
EV Over EBITDA
28.78
EV to Operating CashFlow
-1029.96
EV to FreeCashFlow
-1029.96
Earnings Yield
0.03
FreeCashFlow Yield
-0
Market Cap
11,31 Bil.
Enterprise Value
10,84 Bil.
Graham Number
192.93
Graham NetNet
13

Income Statement Metrics

Net Income per Share
5.54
Income Quality
-0.03
ROE
0.01
Return On Assets
0.02
Return On Capital Employed
0.02
Net Income per EBT
0.99
EBT Per Ebit
1.06
Ebit per Revenue
0.39
Effective Tax Rate
0.01

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.42
Operating Profit Margin
0.39
Pretax Profit Margin
0.41
Net Profit Margin
0.41

Dividends

Dividend Yield
0.04
Dividend Yield %
3.5
Payout Ratio
0
Dividend Per Share
5.7

Operating Metrics

Operating Cashflow per Share
-0.15
Free CashFlow per Share
-0.15
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.02
Return on Tangible Assets
0.02
Days Sales Outstanding
1.88
Days Payables Outstanding
9.94
Days of Inventory on Hand
0
Receivables Turnover
194.13
Payables Turnover
36.71
Inventory Turnover
549525999
Capex per Share
0

Balance Sheet

Cash per Share
13,24
Book Value per Share
298,43
Tangible Book Value per Share
298.43
Shareholders Equity per Share
298.43
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-1.26
Current Ratio
23.44
Tangible Asset Value
20,75 Bil.
Net Current Asset Value
0,46 Bil.
Invested Capital
459987000
Working Capital
0,46 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
0.5
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Uniphos Enterprises Limited Dividends
Year Dividends Growth
2004 0
2021 3 100%
2022 6 40%
2023 7 16.67%
2024 6 -20%

Uniphos Enterprises Limited Profile

About Uniphos Enterprises Limited

Uniphos Enterprises Limited engages in trading of chemicals and other products in India. The company also invests in quoted and unquoted securities. Uniphos Enterprises Limited was incorporated in 1969 and is based in Mumbai, India. Uniphos Enterprises Limited is a subsidiary of Nerka Chemicals Private Limited.

CEO
Mr. Bipin Premji Chheda
Employee
2.022
Address
Uniphos House
Mumbai, 400052

Uniphos Enterprises Limited Executives & BODs

Uniphos Enterprises Limited Executives & BODs
# Name Age
1 Mr. Rajnikant Devidas Shroff B.Sc.
MD & Director
70
2 Mr. Kanti Mangalji Thacker
Compliance Officer & Company Secretary
70
3 Mr. K. R. Srivastava
Chief Operating Officer
70
4 Mr. Bipin Premji Chheda
Chief Financial Officer
70

Uniphos Enterprises Limited Competitors

Ucal Fuel Systems Limited Logo
Ucal Fuel Systems Limited

UCALFUEL.NS

(1.0)
Vesuvius India Limited Logo
Vesuvius India Limited

VESUVIUS.NS

(3.5)
Vimta Labs Limited Logo
Vimta Labs Limited

VIMTALABS.NS

(2.5)
Times Guaranty Limited Logo
Times Guaranty Limited

TIMESGTY.NS

(2.0)